MoonLake Immunotherapeutics
MLTX
5 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 4:10 PM | Matthias BodenstedtChief Financial Officer | Sale | 13,653 | $20.02 | $273.3K | 1,172,431(D) | View → |
| Apr 14, 2026 | Apr 16 4:10 PM | Matthias BodenstedtChief Financial Officer | Sale | 2,426 | $19.56 | $47.5K | 1,186,084(D) | View → |
| Apr 13, 2026 | Apr 14 5:55 PM | da Silva Jorge SantosDirector, Chief Executive Officer | Sale | 51,873 | $18.23 | $945.6K | 2,924,893(D) | View → |
| Apr 10, 2026 | Apr 14 5:55 PM | da Silva Jorge SantosDirector, Chief Executive Officer | Sale | 98,127 | $18.41 | $1.8M | 2,976,766(D) | View → |
| Apr 10, 2026 | Apr 10 6:06 PM | Matthias BodenstedtChief Financial Officer | Sale | 1,925 | $19.51 | $37.6K | 1,188,510(D) | View → |
| Apr 9, 2026 | Apr 10 6:06 PM | Matthias BodenstedtChief Financial Officer | Sale | 85,870 | $18.94 | $1.6M | 1,190,435(D) | View → |
| Mar 31, 2026 | Apr 2 4:48 PM | P/Il L Bvf PartnersDirector, 10% Owner | Sale | 3,750,000 | $16.79 | $63.0M | 1,039,238(D) | View → |
Stock Options & Derivatives
No transactions found.